Skip to content
OpenCapital
Get started

Zoetis ZTS Sheep and other — Revenue

Other product segments

Horses
$5.8B+13.9%
Dogs and Cats
$1.35B+11.6%
Parasiticides
$586M+2.4%
Vaccines
$519M+18.2%
Cattle
$399M-0.5%
Dermatology
$349M-7.9%
Anti-infectives
$241M+1.3%
Pain and sedation
$203M-1.9%
Other pharmaceutical
$158M0.0%
Swine
$128M-7.9%
Animal health diagnostics
$117M+12.5%
Poultry
$117M-7.9%
Other Non Pharmaceuticals
$66M-7.0%
Fish
$65M+4.8%
Contract manufacturing & human health
$23M-23.3%

Similar metrics at other companies

Elanco Animal Health Inc. logo
ELANFarm Animal: — Revenue
$642M+17.6%
Phibro Animal Health logo
PAHCAnimal Health — Revenue
$291.23M+12.7%
Elanco Animal Health Inc. logo
ELANCattle — Revenue
$316M+16.2%
Elanco Animal Health Inc. logo
ELANSwine — Revenue
$96M+12.9%
Cencora logo
CORAnimal Health — Revenue
$1.44B+5.3%
Neogen logo
NEOGAnimal Care And Other — Revenue
$5.9M-43.3%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's sheep and other — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's sheep and other — revenue?
Zoetis (ZTS) reported sheep and other — revenue of $21M in Q1 2026.
How has Zoetis's sheep and other — revenue changed year-over-year?
Zoetis's sheep and other — revenue increased by 5.0% year-over-year, from $20M to $21M.
What is the long-term trend for Zoetis's sheep and other — revenue?
Over 4 years (2021 to 2025), Zoetis's sheep and other — revenue has grown at a -1.1% compound annual growth rate (CAGR), from $95M to $91M.
What does sheep and other — revenue mean?
This metric represents the total net sales generated from the sale of health products, including vaccines, parasiticides, and anti-infectives, specifically tailored for sheep and other minor livestock species. It reflects the company's market penetration and demand within the niche production animal health sector. Monitoring this revenue stream helps assess the diversification of the company's livestock portfolio beyond major species like cattle or swine.